Key Points
- Prof. Wang is founder and chairman of Chongqing Medical Focused Ultrasound Technology Development Co., Ltd.
- During his 34-year career in therapeutic ultrasound, he has made pioneering contributions to the field.
- The award recognizes an individual whose efforts have advanced the field and led to a significant number of patient treatments.
Professor Zhibiao Wang, MD, is the recipient of the Foundation’s inaugural Clinical Adoption Award. The award recognizes an individual dedicated to advancing the field of focused ultrasound and whose efforts have led to a significant number of patient treatments.
In 1999, Prof. Wang founded Chongqing Medical Focused Ultrasound Technology Development Co., Ltd. (later renamed Chongqing Haifu Medical Technology Co. Ltd.) and now serves as the chairman. He leads the company’s research in the fields of device development, clinical application, and marketing.
Prof. Wang developed the company’s – and China’s – first high-intensity focused ultrasound therapeutic system that is used to treat malignant tumors (e.g., liver cancer, pancreatic cancer, breast cancer, osteosarcoma, soft tissues sarcoma) and a wide range of benign diseases — such as uterine fibroids and adenomyosis. The Chongqing Haifu device has been exported to 28 countries and regions and has collectively treated more than 200,000 patients with benign and malignant tumors worldwide.
The company has since developed a series of focused ultrasound therapeutic devices to treat non-tumor diseases, such as disease of the vulva surface and cervix, osteoarthritis, allergic rhinitis, soft tissue injury, pain, and more.
Prof. Wang’s career in therapeutic ultrasound has spanned 34 years. He has made pioneering contributions to the field of ultrasound therapy, including breakthroughs in basic research, large medical equipment development, clinical applications, and industry standards.
He is a Professor of Medicine and leads the State Key Laboratory of Ultrasound in Medicine and Engineering at Chongqing Medical University in China.
His contributions to therapeutic ultrasound research have garnered major funding grants and second prize in both the National Technology Invention Award and the National Science and Technology Progress Award. He has published more than 50 scientific papers in leading journals of the field of ultrasound medicine.
“Prof. Wang is a pioneer in the development of focused ultrasound as a revolutionary, noninvasive therapy and its commercialization,” said Foundation Chairman, Neal F. Kassell, MD. “The company he founded is a leading manufacturer of focused ultrasound equipment, and he has had an immeasurable impact on the technology’s trajectory from idea to its adoption as a global standard of care for a wide variety of serious medical disorders.”
Prof. Wang earned his MD from Chongqing Medical University and has been practicing as an Ob-Gyn specialist.
The Foundation’s 8th International Symposium on Focused Ultrasound will be held October 23-27, 2022. The event will take place in-person in Bethesda, Maryland, and virtual attendance is also available.